Rockefeller Capital Management L.P. Acquires 10,512 Shares of Colgate-Palmolive Company $CL

Rockefeller Capital Management L.P. lifted its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 6.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 182,223 shares of the company’s stock after buying an additional 10,512 shares during the period. Rockefeller Capital Management L.P.’s holdings in Colgate-Palmolive were worth $14,399,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. World Investment Advisors lifted its position in shares of Colgate-Palmolive by 102.4% in the fourth quarter. World Investment Advisors now owns 25,704 shares of the company’s stock worth $2,031,000 after buying an additional 13,007 shares during the last quarter. Corient Private Wealth LLC increased its holdings in shares of Colgate-Palmolive by 13.6% during the 4th quarter. Corient Private Wealth LLC now owns 541,110 shares of the company’s stock valued at $42,789,000 after acquiring an additional 64,926 shares during the last quarter. Auto Owners Insurance Co raised its stake in shares of Colgate-Palmolive by 7,802.0% in the 4th quarter. Auto Owners Insurance Co now owns 442,512 shares of the company’s stock valued at $3,497,000 after acquiring an additional 436,912 shares in the last quarter. Gunpowder Capital Management LLC dba Oliver Wealth Management acquired a new stake in Colgate-Palmolive in the 4th quarter worth approximately $133,000. Finally, Mengis Capital Management Inc. lifted its holdings in Colgate-Palmolive by 62.5% in the 4th quarter. Mengis Capital Management Inc. now owns 12,350 shares of the company’s stock worth $976,000 after purchasing an additional 4,750 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 3.4%

Shares of CL stock opened at $91.65 on Wednesday. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. The firm has a market cap of $73.34 billion, a PE ratio of 35.66, a price-to-earnings-growth ratio of 4.67 and a beta of 0.33. The stock has a 50 day moving average of $87.60 and a 200-day moving average of $86.82.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. During the same quarter in the previous year, the firm posted $0.91 earnings per share. Colgate-Palmolive’s revenue was up 8.4% compared to the same quarter last year. On average, equities analysts predict that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be given a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 82.49%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CL. Wall Street Zen downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday, March 29th. Bank of America decreased their price objective on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a report on Friday, April 10th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $99.00 target price on shares of Colgate-Palmolive in a research note on Monday, May 4th. Barclays boosted their target price on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 5th. Finally, Morgan Stanley restated an “overweight” rating on shares of Colgate-Palmolive in a report on Monday, May 4th. Twelve equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average price target of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.